Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease
have pioneered an innovative in situ implantation technique utilizing microneedle arrays, adept at delivering a consortium of therapeutic agents, including stem cells, to fibrotic liver tissues with precision, thereby offering a targeted approach to liver fibrosis, a prevalent chronic liver condition (Fig
Kornblau SM, Qiu YH, Zhou X, Bekele BN, Case JS, Jackson CE, Andreeff M
When a single molecule is proposed to help the liver, the vasculature, the nervous system, and the aging process all at once, the breadth of the claim is itself a reason for caution, not enthusiasm: broad, database-derived promise is exactly the kind of signal that most often fails to survive controlled testing